论文部分内容阅读
目的比较复方米非司酮和米非司酮配伍米索前列醇终止10～14周瘢痕子宫妊娠的临床疗效。方法将102例10～14周瘢痕子宫妊娠要求流产的妇女分成单方组和复方组2组;结果复方组胎儿排出时间短,产时及术后出血量少,优于单方组,且差异有统计学意义(P<0.05)。成功率及完全流产率高于单方组,转经天数及术后阴道流血时间少于单方组但均差异无统计学意义(P>0.05)。结论复方米非司酮配伍米索前列醇用于终止瘢痕子宫妊娠的临床效果优于单方米非司酮。可加速胎儿排出,减少出血量。
Objective To compare the clinical efficacy of compound mifepristone and mifepristone combined with misoprostol to terminate uterine pregnancy in 10 ~ 14 weeks. Methods 102 cases of uterine scar pregnancy 10 ~ 14 weeks were divided into unilateral group and compound group two women; Results The compound group of fetal discharge time is short, less labor and postoperative bleeding, better than unilateral group, and the difference was statistically Significance (P <0.05). The success rate and complete abortion rate were higher than unilateral group, the number of menstruation days and postoperative vaginal bleeding time were less than unilateral group but no significant difference (P> 0.05). Conclusion The clinical efficacy of compound mifepristone and misoprostol for termination of uterine scar pregnancy is better than that of mifepristone alone. Can accelerate the fetus discharge, reduce the amount of bleeding.